Phys Vivas · rheumatological
Complement Deficiencies AND Recurrent Infections — Viva Defence
DCE viva defence for Complement Deficiencies AND Recurrent Infections.
On this page
Study tools
Target exams
Complement Deficiencies AND Recurrent Infections Viva
Long Case Viva Defence
Opening statement
"This patient presents with a problem best framed as Complement Deficiencies AND Recurrent Infections. My priorities are to identify red flags, confirm the mechanism with purposeful investigations, start a sequenced management plan, and integrate multimorbidity and follow-up." [1] [2]
Examiner questions
Q1: "What makes this urgent?" [1]
"I look for threats to airway, perfusion, neurology, metabolism, infection or bleeding, and I escalate those before elective work-up." [1] [2]
Q2: "What is your first investigation package?" [2]
"I order tests that change management now, not a scattergun panel." [1] [2]
Q3: "Walk me through treatment." [1]
"Stabilise, treat the mechanism, prevent complications, and plan monitoring." [1] [2] [3]
Q4: "What is the classic trap?" [2]
"Treating a label without confirming the discriminating mechanism, or delaying escalation." [1] [2]
References8ShowHide
- [1]Mottaghipisheh H, Jahromi AM, Mirzaei F, Meri S, et al. Homozygous C1qA Deficiency Presenting as Early-Onset Systemic Lupus Erythematosus: A Case Report With a Literature Review Case Reports Immunol, 2026.PMID 42147803
- [2]Consolini R, Maestrini G, Abu-Rumeileh S, Costagliola G The Intertwining Between Arthritis and Inborn Errors of Immunity J Clin Med, 2026.PMID 42123030
- [3]Boccon-Gibod I, Fain O, Gobert D, Debord S, et al. French protocol for the diagnosis and management of hereditary angioedema Rev Med Interne, 2025.PMID 41168057
- [4]Schejbel L, Fadnes D, Permin H, Lappegård KT, et al. Primary complement C5 deficiencies - molecular characterization and clinical review of two families Immunobiology, 2013.PMID 23743184
- [5]Xi Y, Yao T, Zhang C, Zhuang T Effectiveness of safety care and clinical nursing pathway in patients undergoing cardiovascular intervention: a randomized controlled trial Perioper Med (Lond), 2026.PMID 42469924
- [6]Marks FJ, Walters SJ, Sutton L, Jacques RM What statistical methods are more appropriate for predicting recruitment at the design stage of a randomised controlled trial? Trials, 2026.PMID 42469922
- [7]Hajiaqaei M, Mohammadi A Transcranial random noise stimulation (tRNS) over the left dorsolateral prefrontal cortex ameliorates emotion dysregulation and executive function: a single-blind, randomized, sham-controlled clinical trial BMC Psychol, 2026.PMID 42469906
- [8]Donadoni M, La Cava L, Bizzi E, Popescu Janu V, et al. Hereditary Angioedema Prophylaxis Therapy: Berotralstat and Lanadelumab Safety Profile Medicina (Kaunas), 2025.PMID 41303734